Artificial Intelligence In Precision Medicine Market to Grow with a CAGR of 9.55% through 2030F
Rising prevalence of
chronic diseases and demand for drug discovery and development are factors
driving the Global Artificial Intelligence in Precision Medicine Market in
the forecast period 2026-2030F
According to TechSci Research report, “Artificial Intelligence In Precision
Medicine Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Artificial Intelligence In
Precision Medicine Market stood at USD 1.24 billion in 2024 and is anticipated
to grow with a CAGR of 9.55% in the forecast period, 2026-2030. The increasing
prevalence of chronic diseases such as cancer, cardiovascular disorders, and
diabetes has highlighted the need for more effective treatment strategies.
Precision medicine, which takes into account an individual's genetic makeup,
lifestyle, and environmental factors, offers a targeted approach to disease
management. AI, with its ability to analyze vast datasets and extract
meaningful insights, enhances the precision of treatment recommendations and
drug discovery processes.
Advancements in AI
technologies, particularly in the areas of machine learning and deep learning,
have paved the way for more sophisticated data analysis. Machine learning
algorithms can identify patterns and correlations in patient data, leading to
improved diagnostics and treatment plans. Deep learning, a subset of machine
learning, enables AI systems to perform complex tasks like image recognition
and natural language processing, further aiding in disease diagnosis and
prognosis.
Browse over XX market data Figures spread through XX Pages and an in-depth
TOC on "Global Artificial Intelligence In
Precision Medicine Market.”
The growth of the global artificial intelligence in precision medicine market
is closely linked to the accumulation of massive amounts of patient data,
including genomic sequences, clinical records, and medical imaging. Genomic
sequencing has become more accessible and affordable, allowing researchers and
clinicians to understand the genetic basis of diseases. AI algorithms can
process this data to identify genetic markers and mutations, facilitating
personalized treatment plans and targeted therapies.
One of the primary goals
of precision medicine is to move away from the one-size-fits-all approach to
healthcare. AI algorithms analyze patient data to identify biomarkers, predict
disease progression, and recommend treatment options tailored to an individual's
unique genetic and physiological characteristics. This personalized approach
not only improves patient outcomes but also minimizes adverse reactions to
medications.
The convergence of AI
and precision medicine has attracted significant investment from both private
and public sectors. Venture capital firms, pharmaceutical companies, and
research institutions are channeling funds into AI-driven precision medicine
startups. This influx of capital supports research and development efforts,
fosters technological innovation, and fuels market growth.
The Global Artificial Intelligence In Precision Medicine Market is segmented
into technology, component, therapeutic application, and company.
Based on therapeutic
application, Neurology is the fastest-growing therapeutic area. This rapid
expansion is driven by the increasing prevalence of neurological disorders such
as Alzheimer's and Parkinson's diseases, which necessitate early and accurate
diagnosis. AI technologies, particularly in imaging and data analysis, enhance
the ability to identify complex neurological conditions, improving patient
outcomes. Advancements in AI facilitate the development of personalized
treatment plans, addressing the unique challenges presented by neurological
diseases. Collaborations between tech companies and healthcare institutions
further accelerate innovation in this field, contributing to the significant
growth of AI applications in neurology within precision medicine.
Based on region, Asia Pacific is the fastest-growing region in the global
Artificial Intelligence in Precision Medicine market due to a combination of
technological advancement, government support, and increasing healthcare
demand. Countries like China, India, Japan, and South Korea are rapidly
adopting AI technologies to modernize healthcare systems and improve diagnostic
accuracy and treatment outcomes. The region’s large and diverse population
contributes to a broad spectrum of medical data, which enhances AI model training
and precision. Governments and private sectors are actively collaborating on
research, infrastructure development, and digital transformation. There is
rising awareness and acceptance of personalized medicine among healthcare
providers and patients. The presence of strong IT talent and rapidly evolving
tech ecosystems further accelerates the development and integration of AI in
healthcare. These factors together position Asia Pacific as a key growth engine
in precision medicine powered by AI.
Major companies operating in Global Artificial Intelligence In Precision
Medicine Market are:
·
Glanbia Plc
·
BioXcel Therapeutics,
Inc.
·
Sanofi S.A.
·
NVIDIA Corp.
·
Alphabet Inc. (Google
Inc.)
·
IBM Technology
corporation
·
Microsoft Corporation
·
Intel Corp.
·
AstraZeneca plc
·
GE HealthCare
·
Enlitic, Inc.
Download Free Sample Report
Customers can also
request 10% free customization on this report.
“The Global Artificial Intelligence in Precision Medicine Market is driven by a
convergence of factors that are transforming the healthcare landscape. The
increasing prevalence of chronic diseases, technological advancements in AI,
big data accumulation, personalized treatment approaches, expedited drug
discovery, investment and funding, regulatory support, and collaborations are
all contributing to the rapid growth of this market. As AI continues to
advance, the field of precision medicine will likely witness even more
innovative solutions that revolutionize patient care and outcomes on a global
scale” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Artificial Intelligence In Precision Medicine Market, By Technology (Deep
Learning, Querying Method, Natural Language Processing, Context-Aware
Processing), By Component (Hardware, Software, Service), By Therapeutic
Application (Oncology, Cardiology, Neurology, Respiratory, Other), By Region
& Competition, 2020-2030F”, has evaluated the future growth potential
of Global Artificial Intelligence In Precision Medicine Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Artificial Intelligence In Precision
Medicine Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com